Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 36 (3), 464-70

Genotyping the Future: Scientists' Expectations About Race/ Ethnicity After BiDil

Affiliations
Review

Genotyping the Future: Scientists' Expectations About Race/ Ethnicity After BiDil

Richard Tutton et al. J Law Med Ethics.

Abstract

The ongoing debate about the FDA approval of BiDil in 2005 demonstrates how the first racially/ethnically licensed drug is entangled in both Utopian and dystopian future visions about the continued saliency of race/ethnicity in science and medicine. Drawing on the sociology of expectations, this paper analyzes how scientists in the field of pharmacogenetics are constructing certain visions of the future with respect to the use of social categories of race/ethnicity and the impact of high-throughput genotyping technologies that promise to transform scientific practices.

Similar articles

See all similar articles

Cited by 4 articles

Publication types

LinkOut - more resources

Feedback